Trial intelligence / Profile preview

Auricular Point Pressing and Atropine for Children With Insufficient Hyperopia Reserve

NCT07475585Not yet recruiting

Start
Mar 2026
Primary completion
Jul 2027
Modality
Small Molecules, Drug Delivery Systems
01

Overview

Randomised trial of NVK002 in myopia (4 arms). Primary endpoints: Change in Axial Length from Baseline at 24 months and Change in Spherical Equivalent Refraction at 24 months. Planned start Mar 2026; status: not yet recruiting.

02

Drugs

NVK002
03

Conditions

myopia

Beyond the preview

Go deeper on NCT07475585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07475585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call